Cited by 560Lymphatic System and DiseasesCancer survivorship and careBreast Cancer Treatment Studies

Arm edema in breast cancer patients

Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., Kahn, K. L.·2001·JNCI Journal of the National Cancer Institute

Abstract

The improvement in the life expectancy of women with breast cancer raises important questions about how to improve the quality of life for women sustaining complications of breast cancer treatment. In particular, attention to common problems, such as arm edema, is of critical importance. We reviewed published breast cancer guidelines and literature identified via MEDLINE(R) searches in an effort to summarize the research literature pertinent to management of breast cancer-related arm edema, including incidence, prevalence, and timing; risk factors; morbidity; prevention; diagnosis; and efficacy of nonpharmacologic and pharmacologic interventions. We found that arm edema is a common complication of breast cancer therapy that can result in substantial functional impairment and psychological morbidity. The risk of arm edema increases when axillary dissection and axillary radiation therapy are used. Recommendations for preventive measures, such as avoidance of trauma, are available, but these measures have not been well studied. Nonpharmacologic treatments, such as massage and exercise, have been shown to be effective therapies for lymphedema, but the effect of pharmacologic interventions remains uncertain. Comparing results across studies is complicated by the fact that the definitions of interventions and measures of outcomes and risk stratification vary substantially among studies. As arm edema becomes more prevalent with the increasing survival of breast cancer patients, further research is needed to evaluate the efficacy of preventive strategies and therapeutic interventions.

Integrity signals

Registry

Crossref · 10.1093/jnci/93.2.96

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combined moderate intensity aerobic and resistance exercise 2-3 times per week for at least 12 weeks improves HRQoL in cancer survivors during and after treatment.

    “Combined moderate intensity aerobic and resistance exercise performed 2–3 times per week for at least 12 weeks results in improvements in HRQoL both during and after treatment(17, 31, 32).”
  • Moderate intensity aerobic training, resistance training, or combined aerobic plus resistance training three times weekly for 8-12 weeks significantly improves self-reported physical function in cancer survivors.

    “Moderate intensity aerobic training, resistance training or combined aerobic plus resistance training performed three times weekly for 8–12 weeks can significantly improve self-reported physical function(31, 32, 44).”
  • Four recent RCTs not included in either systematic review show consistent evidence of small to moderate effect sizes on overall sleep quality for aerobic training, walking, and resistance training.

    “Four recent RCTs not included in either systematic review have shown consistent evidence of small to moderate effect sizes on overall sleep quality for aerobic training(51), in addition to walking specifically(52, 53) and one study reported evidence of benefit for resistance training(31).”
  • The majority of available evidence on safety and efficacy of exercise during and following cancer treatment is from RCTs of supervised and/or home-based prescribed exercise, and trials in breast cancer survivors.

    “the majority of available evidence on the safety and efficacy of exercise during and following cancer treatment is derived from RCTs of supervised and/or home-based prescribed exercise, and trials in breast cancer survivors(17, 31, 32).”

Cites

Flagged first, then by citations

5 of the 119 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., & Kahn, K. L.
Affiliations
  • RAND Corporation (US)
  • University of California, Los Angeles (US)
Corresponding author
Erickson, V. S.
Venue
JNCI Journal of the National Cancer Institute
Published
2001-01-17
Volume
93
Issue
2
Pages
96-111
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2132750024
Cited by
560
References
119
Citations by year
2026: 5 · 2025: 10 · 2024: 13 · 2023: 17 · 2022: 12 · 2021: 14 · 2020: 7 · 2019: 15 · 2018: 18 · 2017: 26 · 2016: 13 · 2015: 22 · 2014: 20 · 2013: 36 · 2012: 35
FWCI
2.33
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
breast cancer, arm edema, lymphedema, axillary lymph node dissection, treatment complications, risk factors, prevention, massage, physical activity, non-pharmacological treatment, pharmacological interventions, quality of life, functional disability, psychological morbidity
MeSH terms
Arm, Axilla, Breast Neoplasms, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Lymphedema, Mastectomy, Risk Factors, Severity of Illness Index, Time Factors, Incidence, Prevalence, Physical Therapy Modalities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review